QUNR [Qunar Cayman Islands] SC 13G: (Original Filing)

[S.S. or I.R.S. Identification No. of Above Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2 Check the Appropriate Box if a Member of a Group* (a) ____ NOT APPLICABLE (b) ____ 3 SEC Use Only ______________________________ 4 Citizenship or Place of Organization MARYLAND Number of 5 Sole Voting Power ** Shares 923,784 Beneficially 6 Shared Voting Power ** Owned By]

QUNR [Qunar Cayman Islands] SC 13G: S.S. or I.R.S. Identification No. of Above Person

[S.S. or I.R.S. Identification No. of Above Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2 Check the Appropriate Box if a Member of a Group* (a) ____ NOT APPLICABLE (b) ____ 3 SEC Use Only ______________________________ 4 Citizenship or Place of Organization MARYLAND Number of 5 Sole Voting Power ** Shares 923,784 Beneficially 6 Shared Voting Power ** Owned By]

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng

[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan Dr. S.K. Chen ChipMOS TECHNOLOGIES (Bermuda) LTD. +886-6-507-7712 s.k._chen@chipmos.com In the U.S. David Pasquale]

By | 2016-03-17T15:49:16+00:00 July 9th, 2014|Categories: Chinese Stocks, IMOS, Webplus ver|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] 6-K: (Original Filing)

[Press Release iKang Announces Appointment of New Independent Director BEIJING, July 8, 2014 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market in terms of revenue in 2013, today announced that the Board of Directors of the Company (the “Board”) has appointed and designated] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]

KANG [iKang Healthcare] 6-K: Press Release iKang Announces Appointment of New Independent

[Press Release iKang Announces Appointment of New Independent Director BEIJING, July 8, 2014 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market in terms of revenue in 2013, today announced that the Board of Directors of the Company (the “Board”) has appointed and designated] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]

Skip to toolbar